PropertyValue
?:abstract
  • Prevalence of anxiety/depression was investigated in 105 COVID‐19 patients at 1‐3 months from virological clearance by Hospital Anxiety and Depression Scale (HADS‐A/D). 30% of patients displayed pathological HADS‐A/D, 52.4% showed persistent symptoms. Pathological HADS‐A/D patients more commonly reported symptom persistence, even after adjustment for age, gender, disease severity. Psychological assessments should be encouraged in COVID‐19 patients’ follow‐up. This article is protected by copyright. All rights reserved.
?:creator
?:doi
?:doi
  • 10.1002/jmv.26459
?:journal
  • J_Med_Virol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/e3e8888220ddc360f35de9bba106ead3d080eb3c.json
?:pmcid
?:pmid
?:pmid
  • 32841387.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Anxiety and depression symptoms after virological clearance of COVID‐19: a cross‐sectional study in Milan, Italy
?:type
?:year
  • 2020-08-25

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/wt1ehikf>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/wt1ehikf>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all